What companies are NVAX's competitors?

Novavax, Inc. (NVAX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does NVAX compare to its peers?

The peer comparison table on this page shows Novavax, Inc. (NVAX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does NVAX operate in?

Novavax, Inc. (NVAX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

NVAX

Novavax, Inc.

NASDAQ·Biotechnology · Healthcare

$9.70$0.29−2.90%

Market cap$1.60B·Market closed·Oct 23 4:00 PM EDT

Frequently Asked Questions About NVAX

What companies are NVAX's competitors?: Novavax, Inc. (NVAX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does NVAX compare to its peers?: The peer comparison table on this page shows Novavax, Inc. (NVAX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does NVAX operate in?: Novavax, Inc. (NVAX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.

NVAX

Novavax, Inc.

NASDAQ·Biotechnology · Healthcare

$9.70$0.29−2.90%

Market cap$1.60B·Market closed·Oct 23 4:00 PM EDT

Peers

Sort:


MRNAMRNAModerna, Inc.	Moderna, Inc.	$200.10	$79.9B
BNTXBNTXBioNTech SE	BioNTech SE	$88.12	$22.1B
PCVXPCVXVaxcyte, Inc.	Vaxcyte, Inc.	$60.43	$9.5B
VALNVALNValneva SE	Valneva SE	$5.26	$494.8M
EBSEBSEmergent BioSolutions Inc.	Emergent BioSolutions Inc.	$6.23	$319.4M
ARCTARCTArcturus Therapeutics Holdings Inc.	Arcturus Therapeutics Holdings Inc.	$9.84	$279.7M
INOINOInovio Pharmaceuticals, Inc.	Inovio Pharmaceuticals, Inc.	$0.90	$62.0M
GOVXGOVXGeoVax Labs, Inc.	GeoVax Labs, Inc.	$0.21	$2.1M
OGENOGENOragenics, Inc.	Oragenics, Inc.	$0.42	$1.9M
SCNISCNIScinai Immunotherapeutics Ltd.	Scinai Immunotherapeutics Ltd.	$0.56	$291.8K

Frequently Asked Questions About NVAX

What companies are NVAX's competitors?: Novavax, Inc. (NVAX)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does NVAX compare to its peers?: The peer comparison table on this page shows Novavax, Inc. (NVAX) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does NVAX operate in?: Novavax, Inc. (NVAX) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification: companies with similar revenue mix, cost structure, and customer demand drivers.